Fennec Pharmaceuticals Inc.

FENCNASDAQHealthcare● Active

$8.90

+$0.20(+2.30%)

Market Cap$254362223

P/E Ratio—

52W High$10.45

52W Low$5.65

Avg Volume257K

Open$9.00

Beta1.08

Net Income Financials Revenue

Fennec Pharmaceuticals Inc. (FENC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

FENC · net income · updated Jun 9, 2026

Core profitability metrics

FENC · net income · margin · TTM · CAGR

Net income was −$9.7M for FY2025 (fiscal year ending 2025-12-31), down 2134.2% year-over-year. Net profit margin was -21.8%. Based on available data, Fennec Pharmaceuticals Inc. has been profitable since at least 2011.

FY2025 Net Income−$9.7M▼ -2134.2% YoY

Trailing 12M (TTM)−$8.4Mtrailing 4 quarters sum

Net Profit Margin-21.8%−$9.7M ÷ $44.6M

YoY Change-2134.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · FENC net income history · FENC profit margin

Annual net income data

FENC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$9.7M▼ 2134.2%-21.8%$44.6M

FY2024Loss−$436,000▲ +97.3%-0.9%$47.5M

FY2023Loss−$16.0M▲ +32.3%-75.5%$21.3M

FY2022Loss−$23.7M▼ 36.7%-1544.9%$1.5M

FY2021Loss−$17.3M▲ +4.2%—$0

Net income vs peers (Healthcare)

FENC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Fennec Pharmaceuticals Inc.YOU

FENC

−$9.7M-2134.2%-21.8%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Fennec Pharmaceuticals Inc. (FENC) reported net income of −$9.7M for FY2025 (fiscal year ending 2025-12-31), down 2134.2% year-over-year. The net profit margin was -21.8% — meaning the company kept $-0.22 of every dollar of revenue as profit.

Based on available data, Fennec Pharmaceuticals Inc. has been profitable since at least 2011. Net income reached a peak of $4.7M in FY2011. Data available for 15 fiscal years.

Fennec Pharmaceuticals Inc.'s net profit margin was -21.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Fennec Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from FENC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

FENC net income · 4 questions

Fennec Pharmaceuticals Inc. is not currently profitable on an annual basis. The company reported a net loss of $9.7M for FY2025.

is FENC profitabledoes FENC make a profitFENC profitabilityFENC profitable company

▸ Source: FMP /income-statement · GAAP · Fennec Pharmaceuticals Inc. · Fennec Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026